1. Introduction {#s0005}
===============

An estimated 24.0 million persons were current cannabis users in the United States (U.S.) in 2016 and this number has been increasing ([@bb0050]; [@bb0145]). As of January 2018, the District of Columbia and 8 states in the U.S. had legalized cannabis for both recreational and medicinal use ([@bb0050]), a phenomenon that coincides with a steady decline in the perception that cannabis use is "risky" to health ([@bb0065]). Smoking is the most common method of cannabis consumption ([@bb0130]). Cannabis smoking most often occurs indoors ([@bb0015], [@bb0010]), where it is associated with high concentrations of air particles ([@bb0070]) that can be inhaled by children and other nonsmokers in the home. In 2015, 5.3 to 8.0 million children in the U.S. lived with a parent who was a current cannabis user, and among parents, both current cannabis use and daily use are increasing ([@bb0045]). Despite the expansion of legalization and use, there are no laws or restrictions in place to protect children from exposure to cannabis smoke.

Secondhand smoke (SHS) is the smoke exhaled by a smoker or smoke from combusted products such as cigarettes and cannabis. Current literature supports a causal association of exposure to secondhand tobacco smoke (STS) from cigarettes with illnesses in children such as cardiovascular and respiratory damage ([@bb0030]; [@bb0035]; [@bb0080]; [@bb0085]; [@bb0125]; [@bb0140]). Tobacco and cannabis smoke contain many of the same chemicals, such as nitric oxide and aldehydes, which are known to have harmful health effects ([@bb0110]). Given that STS and secondhand cannabis smoke (SCS) particles are equally capable of entering the body and have a similar chemical composition ([@bb0095]; [@bb0195]), studies of the health effects of SCS are warranted.

Children are more sensitive to respiratory insult from STS exposure because of their underdeveloped respiratory and immune systems ([@bb0105]; [@bb0120]). According to the U.S. Surgeon General Reports, the most common health outcomes of child exposure to STS are ear infections, asthma attacks, and poor respiratory health ([@bb0020]; [@bb0160], [@bb0165]). Children may also be exposed to thirdhand smoke (THS), which is SHS that accumulates in dust and on surfaces and includes similar carcinogens and toxicants found in SHS ([@bb0100], [@bb0095]). THS exposure can result from contact with contaminated surfaces where STS has settled, from re-emitted particles or gasses, or from new pollutants created when residual smoke components react with other environmental factors ([@bb0100], [@bb0095]). Children who have been exposed to THS from tobacco had higher odds of atopic eczema ([@bb0075]). It is unknown whether cannabis exposure (either secondhand or thirdhand) is similarly related to health outcomes since few studies have been conducted on the topic, in part due to the federal illegality of cannabis ([@bb0025]).

Cannabis smoking is implicated in several adverse health-related outcomes in adults (e.g. symptoms of chronic bronchitis and behavioral change), while evidence of therapeutic effects and the effects of long-term use remain inconsistent ([@bb0170], [@bb0175]). The only evidence of SCS-related cardiovascular health effects is from a recent study in rats that showed SCS exposure reduced vascular function more than STS exposure, suggesting cannabis smoke may have worse cardiovascular consequences than tobacco ([@bb0185]). In children, the research literature pertaining to the health consequences of cannabis exposure are limited to cases of accidental ingestion ([@bb0005]; [@bb0040]; [@bb0090]; [@bb0180]).

This paper explored the relationship between reported indoor SCS and health outcomes in children. Given that there is no risk-free level of exposure to STS ([@bb0160]), and the qualitative similarity in chemical composition between SHS from cigarettes and cannabis ([@bb0110]), it is plausible that SCS could cause ear infections, asthma, other respiratory dysfunction, and skin conditions. To our knowledge, there is no research on the effects of indoor SCS exposure on health outcomes in children.

2. Methods {#s0010}
==========

2.1. Study design {#s0015}
-----------------

We examined data from *Project Fresh Air* (PFA), a randomized controlled trial of real-time feedback and coaching aimed to reduce indoor SHS and fine particle levels in low-income homes throughout San Diego County, CA. The cross-sectional analyses presented in this paper used data collected during the period of PFA before any intervention took place.

2.2. Participants {#s0020}
-----------------

Families were eligible for enrollment if the primary adult participant was at least 18 years old, with no plans of moving for 3 months, and if the household included at least one adult cigarette smoker and at least one child under the age of 14. In each household, one parent/guardian and the youngest child were enrolled. Details of participant recruitment and enrollment are reported elsewhere ([@bb0060]). Two hundred and ninety-eight participating families enrolled. Parents (or guardians) provided written informed consent for inclusion in this study. Study procedures were approved by the San Diego State University Institutional Review Board (IRB).

2.3. Measures {#s0025}
-------------

Research assistants (RAs) placed customized Dylos DC1700 air particle monitors in participant homes in the room where the most smoking took place. The monitors counted indoor air particles (0.5--2.5 μm in diameter), which have previously been used to detect indoor smoking ([@bb0155]). Air particle monitors continuously collected data throughout the period of study participation. After approximately 7 days of air particle monitoring, RAs administered computer-assisted interviews to assess household behaviors that may affect indoor PM~2.5~ (particulate matter ≤2.5 μm) levels (e.g. smoking and air ventilation), demographic information, and health information about the youngest child in the family.

### 2.3.1. Primary outcome {#s0030}

Parents (or guardians) reported their child\'s 1) past year use of an emergency department (ED) for coughing or difficulty breathing, and whether in the past year the child had a physician-diagnosed 2) ear infection, 3) bronchitis or bronchiolitis, 4) asthma, or 5) skin conditions such as eczema or atopic dermatitis. From these five survey responses, the cumulative number of health outcomes was computed for each child and categorized into three levels (0, 1, or ≥2 outcomes).

### 2.3.2. Cannabis and tobacco smoke exposure {#s0035}

We measured the enrolled child\'s potential exposure to cannabis and cigarette smoke with three dichotomous variables derived from responses to three questions. SCS exposure, the primary exposure of interest for this study, was derived from the question, "How often in the past 7 days did anyone smoke medicinal or recreational marijuana in your home?" Responses were coded 1 if one or more days were reported, and 0 otherwise. Exposure to cigarette smoke, which served as our main measure of STS exposure, was derived from the question: "In the past 7 days, was \[child\'s name\] exposed to any cigarettes in your home, a car, or any other place?" In a sensitivity analysis, we used the response to the following question as an alternate measure of STS exposure: "How often in the past 7 days did anyone smoke cigarettes in your home?" Responses were coded 1 if one or more days were reported, and 0 otherwise.

### 2.3.3. Air particle concentrations {#s0040}

Reported indoor cannabis and cigarette smoking behaviors were compared to using 7-day mean air particle concentrations. Air particle monitors counted indoor air particles each second and averaged particle counts every 10 s. Arithmetic mean particle concentrations (counts per 0.01 cubic foot) were computed for each day.

### 2.3.4. Potential covariates {#s0045}

For the child, the main demographics of interest were age (years), gender (male/female), and race/ethnicity (non-Hispanic White, Hispanic, non-Hispanic Black, or non-Hispanic Other). "Other" included Native American, Asian, Pacific Islander, mixed and unspecified. For the parent or guardian, years of education were categorized as \<12 years, 12 years, and \>12 years and served as a proxy for socioeconomic status.

2.4. Statistical analysis {#s0050}
-------------------------

Of the 298 families enrolled in PFA, 6 participants were asked about cannabis use but declined to answer and 78 were not asked about cannabis because they were either pilot participants (*n* = 36), or participants (*n* = 26) recruited from a group for whom we did not have IRB approval to inquire about cannabis use. An additional 16 participants were not asked about cannabis due to interviewer error (administration of the wrong interview). Of those who answered the cannabis use question, 19 did not provide all health information about their youngest child, 2 did not provide information about education, and 1 did not answer the SCS exposure question. Therefore, data from 192 families were available for the present study.

Health outcomes and covariates were summarized using frequencies and means for the total sample and stratified by indoor cannabis smoking. Group differences were tested using Pearson chi-square test, Fisher\'s Exact Test, and *t*-tests.

Reports of indoor smoking behaviors were confirmed using air particle concentrations. Daily arithmetic mean air particle concentrations were log transformed to better approximate normal distributions. Geometric means (GMs) were computed to summarize particle concentrations during the 7-day period corresponding with the interview for each smoking behavior group: no smoking, cigarette smoking only, cannabis smoking only, or both cigarette and cannabis smoking. Overall group differences were tested using one-way ANOVA. To test the hypothesis that any type of indoor smoking, in relation to no smoking, would increase particle concentrations, between-group differences were computed using Tukey multiple comparison tests.

Ordinal logistic regression was used to assess the relationship of indoor cannabis smoking (yes/no) with the ordinal measure of adverse health outcomes (0, 1, or ≥2 outcomes), adjusting for covariates. Covariates were included in the models if they were related to the number of adverse health outcomes using a threshold of *p* \< 0.40 for inclusion. Three ordinal regression models were fit: Model 1 was unadjusted; Model 2 adjusted for two covariates (child\'s age and parent\'s education); and to test whether associations were independent of exposure to tobacco smoke, Model 3 added a third covariate (reported child exposure to cigarette smoke). As a sensitivity analysis, we repeated our three-model approach, replacing child exposure to cigarette smoke with reported indoor cigarette smoking. Proportional odds assumptions were tested for each model using the *brant()* function in R (R Foundation for Statistical Computing; Vienna, Austria); no violations were observed ([@bb0135]).

All statistical tests were two-tailed with an alpha of 0.05. Data analysis was performed using R (version 3.5.1 for Mac OS X).

3. Results {#s0055}
==========

3.1. Sample characteristics {#s0060}
---------------------------

Indoor cannabis smoking was reported by 29 (15.1%) parents or guardians ([Table 1](#t0005){ref-type="table"}). Indoor cigarette smoking was most prevalent (48.1%) among those who reported indoor cannabis smoking (*p* \< 0.01). Children in cannabis-smoking homes were significantly older (4.72 years) than those who were not (4.12 years; p \< 0.01). Among enrolled parents or guardians who did not report indoor cannabis smoking, most (65.0%) reported \>12 years of education (*p* = 0.03). While enrolled child racial-ethnic backgrounds among households that reported indoor cannabis smoking were relatively evenly distributed, the majority (55.2%) of enrolled children in households that did not report indoor cannabis smoking were Hispanic (*p* = 0.01). Additional sample characteristics by indoor cannabis smoking status are provided in [Table 1](#t0005){ref-type="table"}.Table 1Child and household characteristics by indoor cannabis smoking status among study participants in San Diego County, CA (*N* = 192).Table 1CharacteristicNo indoor cannabis smokingAny indoor cannabis smokingp-value[a](#tf0005){ref-type="table-fn"}(*n* = 163)(*n* = 29)n (%)n (%)Past 7-day child exposure to cigarette smoke0.62 No51 (31.3)11 (37.9) Yes112 (68.7)18 (62.1)Indoor cigarette smoking[b](#tf0010){ref-type="table-fn"}**\<0.01** No127 (78.9)15 (51.7) Yes34 (21.1)14 (48.3)Age of child[c](#tf0015){ref-type="table-fn"} (years)4.12 (3.70)4.72 (3.84)**\<0.01**[d](#tf0020){ref-type="table-fn"}Gender of child0.56 Male86 (52.8)13 (44.8) Female77 (47.2)16 (55.2)Parent education (years completed)**0.03** \<1230 (18.4)4 (13.8) 1227 (16.6)11 (37.9) \>12106 (65.0)14 (48.3)Race/ethnicity of child**0.01**[e](#tf0025){ref-type="table-fn"} Hispanic90 (55.2)7 (24.1) Non-Hispanic Black20 (12.3)6 (20.7) Non-Hispanic White25 (15.3)7 (24.1) Non-Hispanic other[f](#tf0030){ref-type="table-fn"}28 (17.2)9 (31.0)[^1][^2][^3][^4][^5][^6][^7]

3.2. Air particle concentration results {#s0065}
---------------------------------------

GM particle concentrations (counts/0.01ft^3^) were used to test our hypothesis that homes with any type of smoking would have higher 7-day average particle levels than non-smoking homes ([Table 2](#t0010){ref-type="table"}). Cannabis-only homes, cigarette-only homes, and dual-smoking homes were all significantly higher in GM particle concentrations than homes that did not report indoor smoking (all p\'s \< 0.05). There was no difference in particle concentrations between cigarette-only and cannabis-only homes (*p* = 0.99) and both groups had higher concentrations than non-smoking homes (p\'s \< 0.05). Overall, results confirmed our assumption of higher particle concentrations in homes that reported indoor cannabis or cigarette smoking, and showed twice as high concentrations in homes with both indoor cannabis and cigarette smoking.Table 2Geometric mean 7-day indoor air particle concentrations by smoking group among study participants in San Diego County, CA (N = 192).Table 2Reported indoor smoking behaviorMean[a](#tf0035){ref-type="table-fn"}SDp-value[b](#tf0040){ref-type="table-fn"}No smoking19681.71referenceCannabis only31312.10**0.01**Cigarette only30951.85**\<0.01**Cannabis and cigarette60062.42**\<0.01**[^8][^9][^10][^11][^12]

3.3. Health outcomes {#s0070}
--------------------

Among the children who lived in households with indoor cannabis smoking, 31.0% had no adverse health outcomes, 44.8% reported 1 outcome, and 24.1% reported 2 or more outcomes Detailed information about specific health outcomes are in [Table 3](#t0015){ref-type="table"}.Table 3Frequency of past-year adverse health outcomes by indoor cannabis smoking behavior among study participants in San Diego County, CA (N = 192).Table 3OutcomeNo indoor cannabis smokingAny indoor cannabis smokingp-value[a](#tf0045){ref-type="table-fn"}n (%)n (%)Cumulative health outcomes[b](#tf0050){ref-type="table-fn"}**0.04**086 (52.8)9 (31.0)140 (24.5)13 (44.8)≥237 (22.7)7 (24.1)ED visits[c](#tf0055){ref-type="table-fn"}0.58[d](#tf0060){ref-type="table-fn"}None137 (84.1)26 (86.7)Any26 (15.9)3 (10.3)Ear infection0.77[d](#tf0060){ref-type="table-fn"}No140 (85.9)24 (82.8)Yes23 (14.1)5 (17.2)Bronchitis/bronchiolitis0.67[d](#tf0060){ref-type="table-fn"}No154 (94.5)27 (93.1)Yes9 (5.5)2 (6.9)Asthma0.99[d](#tf0060){ref-type="table-fn"}No143 (87.7)26 (89.7)Yes20 (12.3)3 (10.3)Skin conditions0.96No131 (80.4)24 (82.8)Yes32 (19.6)5 (17.2)[^13][^14][^15][^16][^17]Table 4Association of number of past-year adverse health outcomes with indoor cannabis smoke exposure, in three ordinal regression models (N = 192).Table 4VariableModel 1Model 2Model 3OR(95% CI)p-valueaOR(95% CI)p-valueaOR(95% CI)p-valueIndoor cannabis smoking0.120.100.10None1.00(reference)1.00(reference)1.00(reference)Any1.75(0.86--3.54)1.84(0.89--3.81)1.83(0.89--3.80)[^18][^19][^20][^21][^22][^23][^24][^25]

In Model 1 (unadjusted), the odds of reporting a greater number of adverse health outcomes were 1.75 (95% CI = 0.86--3.54; *p* = 0.12) times higher for children of families *with* indoor cannabis smoking compared to families *without* indoor cannabis smoking ([Table 4](#t0020){ref-type="table"}). Adjustment for demographic confounders (Model 2) did not substantially change this association (adjusted OR = 1.84; 95% CI = 0.89--3.81; *p* = 0.10). After additional adjustment for exposure to cigarette smoke in the past 7 days (Model 3), the odds of reporting a greater number of adverse health outcomes remained essentially the same (adjusted OR = 1.83; 95% CI = 0.89--3.80; p = 0.10). These results were unchanged in our sensitivity analysis, in which we adjusted for indoor cigarette smoking instead of reported cigarette smoke exposure ([Supplemental Table 1](#ec0005){ref-type="supplementary-material"}). Interactions between cannabis smoke exposure and any of the three covariates were not statistically significant.

4. Discussion {#s0075}
=============

4.1. Summary of findings {#s0080}
------------------------

To our knowledge, this is the first study of the relationship between reported indoor SCS and health outcomes in children. We observed that children living in homes with indoor cannabis smoke had 83% higher odds of adverse health outcomes compared to children in homes with no indoor cannabis smoking. Our exposure of interest, indoor SCS, did not reach thresholds for statistical significance (p = 0.10), possibly due in part to insufficient statistical power. Notably, however, the magnitude and direction of this association persisted even after further adjustment for two different measures of STS exposure. This suggests that exposure to SCS, independent of exposure to STS, may be related to some of the same adverse health outcomes with which STS has been shown to be associated.

We confirmed reports of indoor smoking with objective measures from air particle monitors, giving us higher confidence in our measure of SCS exposure. The analysis also showed that homes with one indoor smoking behavior had higher particle concentrations than homes without indoor smoking. Homes with both smoking behaviors had two times the daily mean particle concentrations of homes in any other group (all p\'s \< 0.01), suggesting that children may be exposed to more smoke in dual-use homes. This is particularly important given that cannabis users primarily smoke indoors ([@bb0015], [@bb0010]) and are more likely to smoke tobacco as well ([@bb0045]; [@bb0115]; [@bb0195]).

4.2. Relation to previous work {#s0085}
------------------------------

Recent studies have examined the acute effects of SCS in rats and human adults. Flow-mediated dilation (FMD) is used to examine vasodilator function and has been shown to be associated with cardiovascular events in humans ([@bb0150]). One study examined the effects of STS and SCS exposure on femoral artery FMD in rats ([@bb0185]). Investigators concluded that both SCS and STS impaired FMD, suggesting that SCS might have the same effect as STS in humans. The authors also found that neither tetrahydrocannabinol (THC), the main psychoactive component in cannabis, nor nicotine were required in their respective SHS for rats to exhibit FMD impairment, suggesting that the cardiotoxic effects of SHS might be attributable to the smoke rather than the main active ingredients in cigarettes and cannabis. In humans, Herrmann et al. showed that exposing non-smokers to SCS resulted in significantly higher blood/urine THC levels and decreased cognitive ability, effects that depended on the ventilation levels in the smoking chamber ([@bb0055]). In a clinical sample of children presenting to a Colorado hospital with bronchiolitis, the urinary biomarker for SCS exposure, 11-nor-9-carboxy-THC (COOH-THC), was detected among 16% of those tested ([@bb0195]). The prevalence of exposure was even higher among children with urinary-cotinine-confirmed exposure to cigarette SHS, with 56% testing positive for COOH-THC ([@bb0195]). These findings suggest that children are exposed to both STS and SCS in the real world and their exposure to SHS could have played a role in the children\'s hospitalization.

To our knowledge, previous research has not explored the health effects of chronic exposure to SCS. However, our current findings and those from [@bb0195] suggest the possibility of important health effects that warrant further exploration. Given our results and recent rise in cannabis smoking ([@bb0050]; [@bb0145]), it is crucial for studies investigating the effects of STS exposure on child health to measure and test for effects of SCS. Failure to consider SCS may result in an underestimate of the overall effects of smoke exposure on children. Future epidemiologic studies that include SCS biomarkers and/or measures of exposure duration, the environment in which exposure occurs, and THC potency may better characterize exposure and provide more detail about the nature of associations ([@bb0190]). Future longitudinal studies should follow initially healthy children of parents who regularly use cannabis and parents who do not use cannabis to prospectively assess the relationship between SCS and child health outcomes.

5. Strengths and limitations {#s0090}
============================

There are three main strengths to this study. First, examination of the health effects of SCS exposure on children represents a novel and important area of research. Second, the study is timely due to the recent increases in recreational cannabis legalization at the state level in the U.S. Third, subjective measures of smoking behaviors were confirmed using objective measures of air particle concentrations.

Our primary limitation was our measure of potential cannabis exposure to children. Although we obtained parent/guardian reports of child exposure to indoor cigarette smoking, we did not have a parallel question soliciting reports of child exposure to indoor cannabis smoking. Therefore, the best proxy for indoor cannabis smoke exposure was the report of frequency of indoor cannabis smoking.

The analyses were limited by the small proportion of homes in which marijuana smoking was reported. The high ratio of unexposed to exposed limited statistical power. Recreational cannabis use was illegal in California during the PFA study period, and therefore reported measures of indoor cannabis smoking may have been especially prone to reporting bias or social-desirability bias. Underreporting of indoor cannabis smoking would likely reduce the magnitude of association observed in our study. Our results may lend to conclusions of a null association. However, given the consistency of the magnitude of association after successive control for confounding variables, it is plausible that a true effect exists, justifying additional research.

Our sample was primarily Hispanic and low income, limiting representativeness. An additional limitation was the low sensitivity of the past-year health outcomes measures. We did not collect data about the extent to which the adverse health outcomes were exacerbated by any type of SHS. We also did not ask if the outcomes manifested prior to the past year of report. Therefore, we did not capture acute or long-term health effects of any SHS exposure. Future studies should ask questions about the duration and severity of past-year diagnoses in children. Furthermore, the cross-sectional design did not lend to drawing conclusions about a possible causal relation of SCS to health consequences.

6. Conclusions {#s0095}
==============

This study provides some of the first findings concerning potential health implications for children exposed to secondhand cannabis smoke. We found a relatively strong though not statistically significant association (adjusted OR = 1.83; 95% CI = 0.89--3.80; *p* = 0.10) between indoor cannabis smoking and adverse health outcomes in children. Assuming the null hypothesis is true, that there is no association between indoor cannabis smoking and adverse health outcomes in children, the probability is 10% that we would observe an odds ratio of this magnitude in our study. Especially given the potential health risks at stake, the increasing rates of cannabis use, and the less than ideal characteristics of our study (e.g., use of reported measures and limited statistical power), the observed association is sufficient to warrant further research to more decisively determine possible health impacts of indoor cannabis smoking. Ideally, future studies should use higher fidelity measures (e.g., biomarkers of cannabis and cigarette exposure, medical record data), and a stronger design (e.g., larger sample size, longitudinal cohort). With the rise of cannabis use in the U.S., we need to understand its health consequences. Such information is needed to help healthcare providers, lawmakers, and researchers encourage parents and other caregivers to protect children from potentially harmful exposure to SCS.

The following is the supplementary data related to this article.Supplemental Table 1Association of number of past-year adverse health outcomes with indoor cannabis smoke exposure, in three ordinal logistic regression models (sensitivity analyses; n = 190).Supplemental Table 1

Conflicts of interest {#s0100}
=====================

The authors declare that no competing interests exist.

Funding {#s0105}
=======

Research reported in this publication was supported by the National Heart, Lung, and Blood Institute of NIH under award number RO1HL103684 (MH) and under training grant T32HL079891--11 (JB).

The authors would like to thank all Project Fresh Air participants, staff, supervisors, and other collaborators for their contributions to this study. The San Diego State University IRB approved the procedures for this study (IRB Study Number Temp-0961).

[^1]: Bolded p-values indicate statistical significance at *p* \< 0.05.

[^2]: *P*-values are derived from Pearson chi-square tests to test for group differences.

[^3]: *n* = 190 due to missing responses.

[^4]: Indicates use of mean and standard deviation.

[^5]: Indicates *p*-values from two-sample *t*-tests with equal variance.

[^6]: Indicates p-values from Fisher\'s Exact Test, used when expected cell sizes were \<5.

[^7]: "Non-Hispanic Other" includes: Native American, Asian, Pacific Islander, mixed, unspecified.

[^8]: There were no significant differences between the means of the "Cannabis only" and "Cigarette only" groups (*p* = 0.99).

[^9]: The "Cannabis and cigarette" group was significantly different from all other smoking groups (p\'s \< 0.05).

[^10]: Bolded p-values indicate statistical significance at p \< 0.05.

[^11]: Indicates means derived from unadjusted geometric mean particle concentrations (counts/0.01ft^3^) from last 7 days before baseline interview.

[^12]: P-values from Tukey multiple comparisons of geometric means comparing smoking behaviors to "No smoking."

[^13]: Bolded p-values indicate statistical significance at an alpha \<0.05.

[^14]: P-values are derived from Pearson chi-square tests to test for group differences.

[^15]: Cumulative health outcomes include any reports of ED visits, ear infection, bronchitis/bronchiolitis, asthma, or skin conditions in the past year.

[^16]: Visits to an emergency department (ED) for coughing or difficulty of breathing.

[^17]: Indicates p-values derived from Fisher\'s Exact Test, used when expected cell sizes were \< 5.

[^18]: The three-level health outcome variable was used as the dependent variable in all 3 models.

[^19]: Specifications of independent variables in the 3 models were as follows:

[^20]: Model 1: Indoor cannabis smoking.

[^21]: Model 2: Model 1, and age of child, and education level of parent (or guardian).

[^22]: Model 3: Model 2, and past 7-day child exposure to cigarette smoke.

[^23]: OR = Odds ratio.

[^24]: aOR = Adjusted odds ratio.

[^25]: CI = Confidence interval.
